Key result
Novel semiautomated RCU-V method for 99mTc-pyrophosphate SPECT/CT achieves 100% sensitivity for detecting cardiac ATTR amyloidosis.
Why the study?
The study aimed to evaluate the diagnostic accuracy of a novel semiautomated method for calculating relative myocardial wall uptake of 99mTechnetium-pyrophosphate SPECT/CT in suspected cardiac transthyretin amyloidosis.
Does 99mTechnetium-pyrophosphate SPECT/CT with novel semiautomated quantification improve diagnostic accuracy for detecting cardiac transthyretin amyloidosis in patients with suspected ATTR?
Observational (n=108)
Does 99mTechnetium-pyrophosphate SPECT/CT with novel semiautomated quantification improve diagnostic accuracy for detecting cardiac transthyretin amyloidosis in patients with suspected ATTR?
A novel semiautomated SPECT/CT quantification method using relative myocardial wall uptake demonstrates excellent diagnostic accuracy for detecting cardiac transthyretin amyloidosis.
Answers are grounded in this paper and cite their sources.
Semiautomated RCU may aid ATTR diagnosis on Tc-PYP SPECT/CT; leaves open standardization and outcome validation before clinical adoption.
OBJECTIVE: This study aimed to assess the diagnostic accuracy of a novel semiautomated method to calculate relative myocardial wall uptake (RCU) of 99m Technetium-pyrophosphate SPECT/CT in suspected cardiac transthyretin amyloidosis (ATTR). METHODS: Prospective analysis of 108 participants with suspected ATTR. Using novel software, we quantified radiopharmaceutical uptake in the wall of each chamber of the heart at 3 h, calculating RCU for combined ventricular (RCU-V) and whole-heart (RCU-W) measures as a ratio over physiological blood-pool activity. Optimal RCU cut-off ratios were determined using a documented clinical diagnosis of ATTR amyloidosis as the reference standard. RESULTS: The RCU-V method with a cut-off ratio of 1.2 achieved a sensitivity of 100% [95% confidence interval (CI): 90-100%], specificity of 99% (95% CI: 95-100%), and accuracy of 99% (95% CI: 96-100%). The RCU-W method required a higher cut-off ratio of 1.4 to achieve a comparable specificity of 99%. CONCLUSION: This novel SPECT/CT quantification software using the RCU-V method significantly improves diagnostic accuracy for cardiac ATTR and represents an advance compared to existing planar nuclear imaging assessment techniques.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2025) conducted an observational in Suspected cardiac transthyretin amyloidosis (ATTR) (n=108). 99mTechnetium-pyrophosphate SPECT/CT with semiautomated quantification (RCU-V method) vs. Documented clinical diagnosis of ATTR amyloidosis (reference standard) was evaluated on Diagnostic accuracy (sensitivity, specificity, and accuracy) for detecting cardiac ATTR. The novel semiautomated RCU-V method for 99mTc-pyrophosphate SPECT/CT achieved 100% sensitivity (95% CI 90-100%) and 99% specificity (95% CI 95-100%) for detecting cardiac ATTR amyloidosis.
Synapse has enriched 10 related papers. Consider them for comparative context: